Members of the European Parliament demand the abolition of patent protection for coronavirus vaccines. According to them, this will help speed up immunization in the world. The press service of the European Parliament reported this.
“Parliament proposes negotiations start for a temporary waiver of the WTO TRIPS Agreement on patents to improve global access to affordable COVID-19-related medical products,” the statement says.
According to MEPs, Voluntary licencing when the developer of the vaccine decides to whom and under what conditions the patent can be licensed to enable manufacturing is the most important way to scale and speed up global production in the long term.
Besides, European Parliament calls on the US and UK to "immediately lift the ban on the vaccine and raw material exports".
The European Parliament stressed that 70 billion doses are needed for the immunization of 70% of the world's population.
As a reminder, the list of permitted for use in emergencies includes the following vaccines:
- BNT162b2/COMIRNATY Tozinameran (INN) manufactured by Pfizer/BioNTech (registered in Ukraine under the KOMIRNATI name);
- AZD1222 manufactured by AstraZeneca/Oxford (registered in Ukraine under the ASTRAZENECA name);
- Covishield (ChAdOx1_nCoV-19) manufactured by Serum Institute of India Oxford (registered in Ukraine under the COVISHELD name);
- COV2.S manufactured by Janssen;
- mRNA-1273 manufactured by Moderna;
- SARS-CoV-2 Vaccine (Vero Cell), Inactivated (lnCoV) manufactured by Sinopharm/BIBP;
- SARS-CoV-2 Vaccine (Vero Cell), Inactivated manufactured by Sinovac (registered in Ukraine under the CORONAVAC name).
As it was reported earlier, the US has reached an agreement with Pfizer to buy 500 million doses of their coronavirus vaccine to distribute to nearly 100 countries around the world. Biden is expected to announce in the UK on Thursday.